SCHEMBL4335810

SCHEMBL4335810

COc1c(C(=O)NCCc2nccs2)ccc2[nH]nc(-c3cc4ccccc4s3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
COPS5 Q92905 2/20 0.38
PSMD14 O00487 2/20 0.38
STAMBP O95630 1/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
NAMPT P43490 3/20 0.37
MAPK10 P53779 1/20 0.36
STAT6 P42226 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
IKBKB O14920 2/20 0.35
CHUK O15111 2/20 0.35
IKBKG Q9Y6K9 2/20 0.35
EGLN1 Q9GZT9 1/20 0.35
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339889 0.87 BRD4 (0.46) JAK2JAK3COPS5PSMD14STAMBP
SCHEMBL4334496 0.86 MEN1 (0.41) JAK2JAK3COPS5PSMD14STAMBP
SCHEMBL4332920 0.85 JAK2 (0.42) JAK2JAK3MEN1NPC1RAB9A
SCHEMBL4331216 0.84 JAK2 (0.39) JAK2JAK3COPS5PSMD14STAMBP
SCHEMBL13198254 0.84 DRD2 (0.40) JAK2JAK3RAB9ANAMPTMAPK10
SCHEMBL4334929 0.84 LMNA (0.41) JAK2JAK3RAB9ANAMPTMAPK10
SCHEMBL4334979 0.83 MAPT (0.44) MEN1NPC1RAB9AKMT2AMAPK10
SCHEMBL4329228 0.83 HPGD (0.44) JAK2JAK3MEN1NPC1RAB9A
SCHEMBL2865451 0.80 MAPK10 (0.42) JAK2JAK3MAPK10DRD2DRD4
SCHEMBL2861021 0.79 PIP5K1C (0.46) JAK2JAK3NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885COPS5 1294/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885COPS5 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.